CVRx (CVRX) Change in Account Payables (2020 - 2026)
CVRx's (CVRX) quarterly Change in Account Payables came in at -$834000.0 in Q1 2026, down 593.49% year-on-year from $169000.0 in Q1 2025, and down 506.83% quarter-over-quarter from $205000.0 in Q4 2025.
CVRx (CVRX) Change in Account Payables (2020 - 2026) Analysis & Trends
CVRx's Change in Account Payables history runs 7 years deep, the most recent figure standing at -$834000.0 for Q1 2026.
- On a quarterly basis, Change in Account Payables fell 593.49% year-over-year to -$834000.0 in Q1 2026; TTM through Mar 2026 was $248000.0, a 73.43% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, up 79.23% from the prior year.
- Change in Account Payables retreated to -$834000.0 in Q1 2026 per CVRX's latest filing, from $205000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.1 million in Q1 2022 and bottomed at -$1.8 million in Q3 2023.
- The 5-year median for Change in Account Payables is $281000.0 (2025), against an average of $146411.8.
- Biggest YoY gain for Change in Account Payables was 1529.03% in 2022; the steepest drop was 2536.59% in 2022.
- Year by year, Change in Account Payables stood at $443000.0 in 2022, then soared by 69.53% to $751000.0 in 2023, then tumbled by 192.41% to -$694000.0 in 2024, then soared by 129.54% to $205000.0 in 2025, then slumped by 506.83% to -$834000.0 in 2026.
- Per Business Quant, the three latest CVRX Change in Account Payables figures stand at -$834000.0 (Q1 2026), $205000.0 (Q4 2025), and $596000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CVRx | 128.88 Mn | 56.58 Mn | 12.88 Mn | -834,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -834,000.00 |
| Mar 31, 2026 | -834,000.00 |
| Dec 31, 2025 | 205,000.00 |
| Dec 31, 2025 | 205,000.00 |
| Sep 30, 2025 | 596,000.00 |
| Sep 30, 2025 | 596,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Mar 31, 2025 | 169,000.00 |
| Dec 31, 2024 | -694,000.00 |
| Dec 31, 2024 | -694,000.00 |
| Sep 30, 2024 | -240,000.00 |
| Sep 30, 2024 | -240,000.00 |
| Jun 30, 2024 | 908,000.00 |
| Jun 30, 2024 | 908,000.00 |
| Mar 31, 2024 | 724,000.00 |
| Mar 31, 2024 | 724,000.00 |
| Dec 31, 2023 | 751,000.00 |
| Dec 31, 2023 | 751,000.00 |